153 related articles for article (PubMed ID: 8776716)
1. Interactions of excitatory amino acid antagonists with conventional antiepileptic drugs.
Czuczwar SJ; Turski WA; Kleinrok Z
Metab Brain Dis; 1996 Jun; 11(2):143-52. PubMed ID: 8776716
[TBL] [Abstract][Full Text] [Related]
2. Excitatory amino acid antagonists and the anticonvulsive activity of conventional antiepileptic drugs.
Kleinrok Z; Turski WA; Czuczwar SJ
Pol J Pharmacol; 1995; 47(3):247-52. PubMed ID: 8714757
[TBL] [Abstract][Full Text] [Related]
3. Competitive NMDA-receptor antagonists, LY 235959 and LY 233053, enhance the protective efficacy of various antiepileptic drugs against maximal electroshock-induced seizures in mice.
Borowicz KK; Gasior M; Kleinrok Z; Czuczwar SJ
Epilepsia; 1996 Jul; 37(7):618-24. PubMed ID: 8681893
[TBL] [Abstract][Full Text] [Related]
4. Influence of aminophylline and strychnine on the protective activity of excitatory amino acid antagonists against maximal electroshock-induced convulsions in mice.
Tutka P; Turski WA; Kleinrok Z; Czuczwar SJ
J Neural Transm (Vienna); 1996; 103(3):307-14. PubMed ID: 8739842
[TBL] [Abstract][Full Text] [Related]
5. LY 300164, a novel antagonist of AMPA/kainate receptors, potentiates the anticonvulsive activity of antiepileptic drugs.
Czuczwar SJ; Swiader M; Kuźniar H; Gasior M; Kleinrok Z
Eur J Pharmacol; 1998 Oct; 359(2-3):103-9. PubMed ID: 9832379
[TBL] [Abstract][Full Text] [Related]
6. Influence of combined treatment with NMDA and non-NMDA receptor antagonists on electroconvulsions in mice.
Czuczwar SJ; Borowicz KK; Kleinrok Z; Tutka P; Zarnowski T; Turski WA
Eur J Pharmacol; 1995 Aug; 281(3):327-33. PubMed ID: 8521917
[TBL] [Abstract][Full Text] [Related]
7. Perspectives for the use of excitatory amino acid ionotropic receptor antagonists as antiepileptic drugs.
Czuczwar SJ
Pol J Pharmacol; 2000; 52(1):67-70. PubMed ID: 10949125
[TBL] [Abstract][Full Text] [Related]
8. N6-cyclohexyladenosine and 3-(2-carboxypiperazine-4-yl)-1-propenyl-1-phosphonic acid enhance the effect of antiepileptic drugs against induced seizures in mice.
Assi AA
J Pharm Pharm Sci; 2001; 4(1):42-51. PubMed ID: 11302789
[TBL] [Abstract][Full Text] [Related]
9. 2,3-dihydroxy-6-nitro-7-sulfamoylbenzo(F)quinoxaline enhances the protective activity of common antiepileptic drugs against maximal electroshock-induced seizures in mice.
Zarnowski T; Kleinrok Z; Turski WA; Czuczwar SJ
Neuropharmacology; 1993 Sep; 32(9):895-900. PubMed ID: 7694171
[TBL] [Abstract][Full Text] [Related]
10. Influence of antazoline and ketotifen on the anticonvulsant activity of conventional antiepileptics against maximal electroshock in mice.
Swiader M; Wielosz M; Czuczwar SJ
Eur Neuropsychopharmacol; 2004 Aug; 14(4):307-18. PubMed ID: 15163441
[TBL] [Abstract][Full Text] [Related]
11. Influence of a Ca2+ channel agonist, Bay k-8644, on the anticonvulsant activity of NMDA and non-NMDA receptor antagonists.
Czuczwar SJ; Gasior M; Turski WA; Kleinrok Z
Eur J Pharmacol; 1994 Oct; 264(1):103-6. PubMed ID: 7530200
[TBL] [Abstract][Full Text] [Related]
12. Effect of 5-fluoroindole-2-carboxylic acid (an antagonist of the NMDA receptor-associated glycine site) on the anticonvulsive activity of conventional antiepileptic drugs.
Kamiński R; Przywara B; Gasior M; Kleinrok Z; Czuczwar SJ
J Neural Transm (Vienna); 1998; 105(2-3):133-46. PubMed ID: 9660092
[TBL] [Abstract][Full Text] [Related]
13. Antiparkinsonian drugs memantine and trihexyphenidyl potentiate the anticonvulsant activity of valproate against maximal electroshock-induced seizures.
Urbańska E; Dziki M; Czuczwar SJ; Kleinrok Z; Turski WA
Neuropharmacology; 1992 Oct; 31(10):1021-6. PubMed ID: 1436383
[TBL] [Abstract][Full Text] [Related]
14. Influence of N-hydroxymethyl-p-isopropoxyphenylsuccinimide on the anticonvulsant action of different classical antiepileptic drugs in the mouse maximal electroshock-induced seizure model.
Luszczki JJ; Kominek M; Florek-Luszczki M; Tchaytchian DA; Kocharov SL; Zolkowska D
Epilepsy Res; 2012 Jun; 100(1-2):27-36. PubMed ID: 22281062
[TBL] [Abstract][Full Text] [Related]
15. The non-competitive AMPA/kainate receptor antagonist, GYKI 52466, potentiates the anticonvulsant activity of conventional antiepileptics.
Borowicz KK; Gasior M; Kleinrok Z; Czuczwar SJ
Eur J Pharmacol; 1995 Aug; 281(3):319-26. PubMed ID: 8521916
[TBL] [Abstract][Full Text] [Related]
16. Anticonvulsant and adverse effects of MK-801, LY 235959, and GYKI 52466 in combination with Ca2+ channel inhibitors in mice.
Gasior M; Borowicz K; Kleinrok Z; Starownik R; Czuczwar SJ
Pharmacol Biochem Behav; 1997 Apr; 56(4):629-35. PubMed ID: 9130287
[TBL] [Abstract][Full Text] [Related]
17. [Glutamate receptor antagonists as potential antiepileptic drugs].
Czuczwar SJ
Neurol Neurochir Pol; 2000; 34 Suppl 8():41-6. PubMed ID: 11780588
[TBL] [Abstract][Full Text] [Related]
18. The competitive NMDA antagonist, D-CPP-ene, potentiates the anticonvulsant activity of conventional antiepileptics against maximal electroshock-induced seizures in mice.
Zarnowski T; Kleinrok Z; Turski WA; Czuczwar SJ
Neuropharmacology; 1994 May; 33(5):619-24. PubMed ID: 7936096
[TBL] [Abstract][Full Text] [Related]
19. Anti-convulsant and adverse effects of the glycineB receptor ligands, D-cycloserine and L-701,324: comparison with competitive and non-competitive N-methyl-D-aspartate receptor antagonists.
Wlaź P
Brain Res Bull; 1998 Aug; 46(6):535-40. PubMed ID: 9744291
[TBL] [Abstract][Full Text] [Related]
20. The NMDA antagonist procyclidine, but not ifenprodil, enhances the protective efficacy of common antiepileptics against maximal electroshock-induced seizures in mice.
Zarnowski T; Kleinrok Z; Turski WA; Czuczwar SJ
J Neural Transm Gen Sect; 1994; 97(1):1-12. PubMed ID: 7888145
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
